LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 10 of 15: Cell count and normalized growth rate inhibition values within biological replicate 3. - Dataset - HMS LINCS Database

LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 10 of 15: Cell count and normalized growth rate inhibition values within biological replicate 3. - Dataset (ID:20247)

Download: Excel (XLSX), Comma-separated (CSV)

<<<<

Select the entities to show:

Small molecules	Cells

|<
<<
Previous
Page 294 of 535
Next
>>
>
7326 to 7350 of 13356 records
per page:

Cell	Small Molecule	Small Mol Concentration	Small Mol Conc Unit	LJP Library Plate	Replicate	Assay Well	Timepoint	Timepoint Unit	Total Cell Count Before Treatment	Total Cell Count After Treatment	Total Control Cell Count	Relative Cell Count	Normalized Growth Rate Inhibition Value
BT-20	Lapatinib	10	uM	LJP6	3	M19	72	hr	1097	2364	3696	0.6395	0.5497
BT-20	Sirolimus	0.04	uM	LJP6	1	L18	72	hr	1097	2342	3610	0.6487	0.5546
BT-20	Sirolimus	0.04	uM	LJP6	2	L18	72	hr	1097	2241	3713	0.6034	0.5008
BT-20	Sirolimus	0.04	uM	LJP6	3	L18	72	hr	1097	2519	3696	0.6815	0.6069
BT-20	Sirolimus	0.12	uM	LJP6	1	L17	72	hr	1097	2057	3610	0.5697	0.4416
BT-20	Sirolimus	0.12	uM	LJP6	2	L17	72	hr	1097	2242	3713	0.6037	0.5012
BT-20	Sirolimus	0.12	uM	LJP6	3	L17	72	hr	1097	2354	3696	0.6368	0.5459
BT-20	Sirolimus	0.37	uM	LJP6	1	L16	72	hr	1097	2251	3610	0.6235	0.5192
BT-20	Sirolimus	0.37	uM	LJP6	2	L16	72	hr	1097	2099	3713	0.5652	0.4460
BT-20	Sirolimus	0.37	uM	LJP6	3	L16	72	hr	1097	2209	3696	0.5976	0.4908
BT-20	Sirolimus	1.11	uM	LJP6	1	L15	72	hr	1097	2135	3610	0.5913	0.4731
BT-20	Sirolimus	1.11	uM	LJP6	2	L15	72	hr	1097	2127	3713	0.5727	0.4569
BT-20	Sirolimus	1.11	uM	LJP6	3	L15	72	hr	1097	2342	3696	0.6336	0.5414
BT-20	Sirolimus	3.33	uM	LJP6	1	L14	72	hr	1097	2361	3610	0.6539	0.5620
BT-20	Sirolimus	3.33	uM	LJP6	2	L14	72	hr	1097	2284	3713	0.6150	0.5171
BT-20	Sirolimus	3.33	uM	LJP6	3	L14	72	hr	1097	2285	3696	0.6182	0.5199
BT-20	Sirolimus	10	uM	LJP6	1	L13	72	hr	1097	2348	3610	0.6503	0.5570
BT-20	Sirolimus	10	uM	LJP6	2	L13	72	hr	1097	2319	3713	0.6244	0.5303
BT-20	Sirolimus	10	uM	LJP6	3	L13	72	hr	1097	2339	3696	0.6328	0.5403
BT-20	ZSTK474	0.04	uM	LJP6	1	M18	72	hr	1097	3469	3610	0.9608	0.9540
BT-20	ZSTK474	0.04	uM	LJP6	2	M18	72	hr	1097	3510	3713	0.9452	0.9369
BT-20	ZSTK474	0.04	uM	LJP6	3	M18	72	hr	1097	3483	3696	0.9423	0.9333
BT-20	ZSTK474	0.12	uM	LJP6	1	M17	72	hr	1097	2907	3610	0.8051	0.7630
BT-20	ZSTK474	0.12	uM	LJP6	2	M17	72	hr	1097	2612	3713	0.7033	0.6374
BT-20	ZSTK474	0.12	uM	LJP6	3	M17	72	hr	1097	2581	3696	0.6982	0.6293

|<
<<
Previous
Page 294 of 535
Next
>>
>
7326 to 7350 of 13356 records
per page:

HMS LINCS Project

LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 10 of 15: Cell count and normalized growth rate inhibition values within biological replicate 3. - Dataset (ID:20247)